SCHEMBL23920230

SCHEMBL23920230

CC(C)(C)OC(=O)NC[C@H]1CC[C@H](NC(=O)c2cc3cc(Cl)ccc3o2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACB O00763 7/20 0.48
ACACA Q13085 5/20 0.48
PBK Q96KB5 1/20 0.47
ATF4 P18848 2/20 0.47
RAB9A P51151 3/20 0.46
NPC1 O15118 2/20 0.46
HDAC3 O15379 2/20 0.44
HDAC1 Q13547 2/20 0.44
HDAC2 Q92769 2/20 0.44
HDAC4 P56524 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
HDAC9 Q9UKV0 1/20 0.44
HDAC5 Q9UQL6 1/20 0.44
TAS1R3 Q7RTX0 1/20 0.44
TAS1R1 Q7RTX1 1/20 0.44
CTSL P07711 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28720402 1.00 ACACB (0.48) ACACBACACAPBKATF4RAB9A
SCHEMBL29527421 1.00 ACACB (0.48) ACACBACACAPBKATF4RAB9A
SCHEMBL29527441 1.00 ACACB (0.48) ACACBACACAPBKATF4RAB9A
SCHEMBL21050155 0.90 RAB9A (0.51) ATF4RAB9ANPC1HDAC3HDAC1
SCHEMBL21050159 0.90 RAB9A (0.51) ATF4RAB9ANPC1HDAC3HDAC1
SCHEMBL29356799 0.90 RAB9A (0.51) ATF4RAB9ANPC1HDAC3HDAC1
SCHEMBL22373836 0.87 ACACB (0.43) ACACBACACAATF4HDAC3HDAC1
SCHEMBL22777444 0.87 RAB9A (0.54) ATF4RAB9ANPC1HDAC3HDAC1
SCHEMBL22777445 0.87 RAB9A (0.54) ATF4RAB9ANPC1HDAC3HDAC1
SCHEMBL29447009 0.87 RAB9A (0.54) ATF4RAB9ANPC1HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317102-A1 INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY ALTOS LABS, INC. 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317102-A1 INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY ATF4, DDIT3, ATF1 ACACB 862/4885ACACA 1961/4885PBK 4099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.